| Advanced Medical Solution 1 Llc | |
|
4016 River Oaks Drive, Myrtle Beach, SC 29579-8487 | |
| (843) 742-7922 | |
| (843) 796-1492 |
| Full Name | Advanced Medical Solution 1 Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 4016 River Oaks Drive, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174188502 | NPI | - | NPPES |
| Provider Name | Jon Clark Holt |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1083751622 PECOS PAC ID: 1850450453 Enrollment ID: I20081112000188 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago
| Provider Name | Jack D Scott |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1487878195 PECOS PAC ID: 1951456078 Enrollment ID: I20090826000013 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago
| Provider Name | Kimberly Cecchini Purgavie |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1093774028 PECOS PAC ID: 9335100197 Enrollment ID: I20100722000215 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago
| Provider Name | Melissa A Costantini |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386278422 PECOS PAC ID: 5890125181 Enrollment ID: I20200429002030 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago
| Provider Name | Jeremy Lynn Adams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568942696 PECOS PAC ID: 5597007799 Enrollment ID: I20200519000616 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago
| Provider Name | Holly Behr Nicholson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306459417 PECOS PAC ID: 2567872419 Enrollment ID: I20201103002999 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago
| Provider Name | Gene S Harrison |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1366500019 PECOS PAC ID: 0840450573 Enrollment ID: I20210120002434 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago
| Provider Name | Tomasz Szewczyk |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1740580661 PECOS PAC ID: 2062608854 Enrollment ID: I20211118001437 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Advanced Medical Solution 1 Llc 4016 River Oaks Drive, Myrtle Beach, SC 29579-8487 Ph: (843) 742-7922 | Advanced Medical Solution 1 Llc 4016 River Oaks Drive, Myrtle Beach, SC 29579-8487 Ph: (843) 742-7922 |
News Archive
The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.
We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
› Verified 2 days ago